CGNHCardioGenics Holdings Inc.

About CardioGenics Holdings Inc. (CGNH)

CardioGenics Holdings Inc. (CGNH) is a Diagnostics & Research company headquartered in Mississauga, ON, Canada whose shares trade over-the-counter on the Expert Market tier.

Based in Ontario, Canada, CardioGenics is engaged in the development and marketing of a point of care testing device and several diagnostic test products. The point of care testing device is less expensive, easier to use, network ready, provides faster results, and provides lab-quality results within 15 minutes with large advantages over competing products on the market today, including improving patient outcomes and reducing costs associated with such healthcare.

CGNH key facts

Ticker symbol

CGNH

Market tier

Expert Market

Sector

Healthcare

Industry

Diagnostics & Research

Headquarters

Mississauga, ON, Canada

Country of incorporation

US

Year of incorporation

1997

Estimated market cap

$11.9K (as of Apr 16, 2025)

Shares outstanding

118,685,019

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

10/31

CardioGenics Holdings Inc. leadership

• Yahia Gawad — CEO
• Linda J. Sterling — Secretary
• James Essex — CFO

Explore more: Diagnostics & Research stocks · Healthcare sector · Expert Market stocks · OTC stocks starting with C